TTK and neoplasm: Consistent with this idea, inhibition of MPS1, a key regulator of the mitotic checkpoint, by the small-molecule inhibitor NMS-P715 was sufficient to cause cell death in a variety of tumor cell lines and inhibit tumor growth in preclinical cancer models [65].